UPC Analytics
ENDE
Overview · Filed: —

UPC_APP_27426/2025

A CELL MEDIATED IMMUNE RESPONSE ASSAY WITH ENHANCED SENSITIVITY

Procedural & sub-applicationsDocument Access (RoP262)Dusseldorf LDApplication RoP262A—
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • QIAGEN Sciences, LLC
Reps: Clemens Plassmann (Hogan Lovells International LLP); Markus Kuczera (Hogan Lovells International LLP)

Respondents

  • bioMérieux SA
  • bioMérieux Deutschland GmbH
Reps: Oliver Jan Jüngst (Bird & Bird LLP); Annika L. Lückemann (Bird & Bird LLP)
Judges
  • SchumacherJudge-rapporteur
Patents
  • EP 2 726 883
CPC codes: Y02A90/10, G01N33/505, G01N33/56966, G01N33/68

Sector: Measurement & Testing

Outcome
Procedural only
Filed: —
First decided: Jul 15, 2025
Language: —